Transformational cell therapies for patients with pancreatic disease

Stuart Williams

Stuart K. Williams, Ph.D.

Chief Technology Officer (Koligo Therapeutics Inc.) and Executive Director

Stu Williams is an internationally recognized expert in regenerative medicine. He has extensive experience translating cell and tissue-based therapies to human clinical use. He received his Ph.D. in Cell Biology from the University of Delaware followed by postdoctoral training in Pathology at the Yale School of Medicine.

Stu has held faculty appointments at Jefferson Medical College where he was Director of Research in the Department of Surgery, and the University of Arizona where he founded the University of Arizona Biomedical Engineering Program. Most recently Stu established the Bioficial Organs Program at the University of Louisville. He has authored over 400 scientific papers, abstracts, book chapters and editorials. He is a Fellow of the American Heart Association and Fellow of the American Institute of Medical and Biological Engineering

Stu has extensive experience in biotechnology and has been an active consultant to the regenerative medicine, medical device, and pharmaceutical community. His research and development activities have resulted in 24 issued US patents with numerous patents pending. His interest in islet transplantation is long standing and most recently resulted in the formation of Koligo Therapeutics. As Chief Technology Officer of Koligo Therapeutics Stu will continue his efforts to expand the utilization of this technology.

A native of Wilmington, Delaware, Stu enjoys his family, golf and travel when he is not pursuing his life-long interest in biology.

Kyslecel personalized cell therapy for chronic pancreatitis. Because pain should not define your life.